Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1949 1
1950 5
1951 4
1952 4
1953 2
1955 2
1956 4
1957 8
1958 5
1959 2
1960 2
1961 3
1962 2
1963 6
1964 2
1965 4
1966 3
1967 4
1968 2
1969 5
1970 5
1971 6
1972 4
1973 3
1974 3
1975 3
1976 5
1977 10
1978 8
1979 3
1980 5
1981 6
1982 11
1983 8
1984 9
1985 11
1986 13
1987 17
1988 18
1989 21
1990 14
1991 12
1992 15
1993 16
1994 14
1995 19
1996 18
1997 18
1998 19
1999 27
2000 12
2001 18
2002 21
2003 19
2004 14
2005 15
2006 11
2007 16
2008 7
2009 11
2010 18
2011 32
2012 53
2013 40
2014 41
2015 68
2016 68
2017 34
2018 38
2019 35
2020 30
2021 44
2022 23
Text availability
Article attribute
Article type
Publication date

Search Results

1,017 results
Results by year
Filters applied: . Clear all
Page 1
The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients.
Hallin J, Engstrom LD, Hargis L, Calinisan A, Aranda R, Briere DM, Sudhakar N, Bowcut V, Baer BR, Ballard JA, Burkard MR, Fell JB, Fischer JP, Vigers GP, Xue Y, Gatto S, Fernandez-Banet J, Pavlicek A, Velastagui K, Chao RC, Barton J, Pierobon M, Baldelli E, Patricoin EF 3rd, Cassidy DP, Marx MA, Rybkin II, Johnson ML, Ou SI, Lito P, Papadopoulos KP, Jänne PA, Olson P, Christensen JG. Hallin J, et al. Among authors: marx ma. Cancer Discov. 2020 Jan;10(1):54-71. doi: 10.1158/2159-8290.CD-19-1167. Epub 2019 Oct 28. Cancer Discov. 2020. PMID: 31658955 Free PMC article.
Identification of MRTX1133, a Noncovalent, Potent, and Selective KRASG12D Inhibitor.
Wang X, Allen S, Blake JF, Bowcut V, Briere DM, Calinisan A, Dahlke JR, Fell JB, Fischer JP, Gunn RJ, Hallin J, Laguer J, Lawson JD, Medwid J, Newhouse B, Nguyen P, O'Leary JM, Olson P, Pajk S, Rahbaek L, Rodriguez M, Smith CR, Tang TP, Thomas NC, Vanderpool D, Vigers GP, Christensen JG, Marx MA. Wang X, et al. Among authors: marx ma. J Med Chem. 2022 Feb 24;65(4):3123-3133. doi: 10.1021/acs.jmedchem.1c01688. Epub 2021 Dec 10. J Med Chem. 2022. PMID: 34889605 Free article.
Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer.
Fell JB, Fischer JP, Baer BR, Blake JF, Bouhana K, Briere DM, Brown KD, Burgess LE, Burns AC, Burkard MR, Chiang H, Chicarelli MJ, Cook AW, Gaudino JJ, Hallin J, Hanson L, Hartley DP, Hicken EJ, Hingorani GP, Hinklin RJ, Mejia MJ, Olson P, Otten JN, Rhodes SP, Rodriguez ME, Savechenkov P, Smith DJ, Sudhakar N, Sullivan FX, Tang TP, Vigers GP, Wollenberg L, Christensen JG, Marx MA. Fell JB, et al. Among authors: marx ma. J Med Chem. 2020 Jul 9;63(13):6679-6693. doi: 10.1021/acs.jmedchem.9b02052. Epub 2020 Apr 6. J Med Chem. 2020. PMID: 32250617 Free article.
Live Without Regret.
Marx MV. Marx MV. Tech Vasc Interv Radiol. 2018 Mar;21(1):1. doi: 10.1053/j.tvir.2017.12.001. Epub 2017 Dec 15. Tech Vasc Interv Radiol. 2018. PMID: 29471993 No abstract available.
Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease.
Zeissig S, Rosati E, Dowds CM, Aden K, Bethge J, Schulte B, Pan WH, Mishra N, Zuhayra M, Marx M, Paulsen M, Strigli A, Conrad C, Schuldt D, Sinha A, Ebsen H, Kornell SC, Nikolaus S, Arlt A, Kabelitz D, Ellrichmann M, Lützen U, Rosenstiel PC, Franke A, Schreiber S. Zeissig S, et al. Among authors: marx m. Gut. 2019 Jan;68(1):25-39. doi: 10.1136/gutjnl-2018-316023. Epub 2018 May 5. Gut. 2019. PMID: 29730603
German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients.
Rahbar K, Ahmadzadehfar H, Kratochwil C, Haberkorn U, Schäfers M, Essler M, Baum RP, Kulkarni HR, Schmidt M, Drzezga A, Bartenstein P, Pfestroff A, Luster M, Lützen U, Marx M, Prasad V, Brenner W, Heinzel A, Mottaghy FM, Ruf J, Meyer PT, Heuschkel M, Eveslage M, Bögemann M, Fendler WP, Krause BJ. Rahbar K, et al. Among authors: marx m. J Nucl Med. 2017 Jan;58(1):85-90. doi: 10.2967/jnumed.116.183194. Epub 2016 Oct 20. J Nucl Med. 2017. PMID: 27765862 Free article.
In Reply.
Gerber B, Marx M, Untch M, Faridi A. Gerber B, et al. Among authors: marx m. Dtsch Arztebl Int. 2016 Apr 15;113(15):270. doi: 10.3238/arztebl.2016.0270. Dtsch Arztebl Int. 2016. PMID: 27151467 Free PMC article. No abstract available.
Electrophysiological exploration of hearing.
Bakhos D, Marx M, Villeneuve A, Lescanne E, Kim S, Robier A. Bakhos D, et al. Among authors: marx m. Eur Ann Otorhinolaryngol Head Neck Dis. 2017 Oct;134(5):325-331. doi: 10.1016/j.anorl.2017.02.011. Epub 2017 Mar 17. Eur Ann Otorhinolaryngol Head Neck Dis. 2017. PMID: 28330595 Free article. Review.
1,017 results